logo
← ETF skrineri

Loncar Cancer Immunotherapy ETF

CNCR

Loncar Cancer Immunotherapy ETF (CNCR) Akinda fond skriningi (AAOIFI asosida) bo'yicha: Halol emas. Qamrov 77.21%. Quyida: fond beshta standart bo'yicha, fond ma'lumotlari va har bir aktiv o'z hukmi bilan.

Akinda fond skriningi

Akinda fond skriningi (AAOIFI asosida)Halol emasQamrov: 77.21%
  • Halol 26.97%
  • Shubhali 0.00%
  • Halol emas 50.25%
  • Baholanmagan 22.79%

Chiziq kenglikka moslashtirilgan; raqamlar berilganicha ko'rsatilgan va ulushlar yig'indisi har doim ham 100% bo'lmaydi.

Qamrov — fond ulushining biz yaroqli hukmga ega bo'lgan qismi. 95% dan past qamrovda fond faqat ko'rinadigan qism allaqachon 5% chegaradan oshgan bo'lsa baholanadi; aks holda u bu usulda baholanmaydi.

Fond haqida

Emitent
—
Birja (qayerda savdo qilinadi)
AQSh
Domitsil (qayerda ro'yxatdan o'tgan)
AQSh
Hisobot valyutasi
USD
Xarajat koeffitsienti
0.79%
Aktivlar (AUM)
12.73M USD
Aktivlar soni
31 (23 tekshirilgan)
Savat sanasi (provayder)
17 Apr 2023
Savat Akinda tomonidan yuklangan
30 Oct 2026
Hukm yangilangan
3 Nov 2026

Maydon — fond savdo qilinadigan joy; ro'yxat davlati — u ro'yxatdan o'tgan joy. London fondlari Irlandiya yoki Lyuksemburgda ro'yxatdan o'tgan, shuning uchun Buyuk Britaniya ETFlari uchun «Maydon»dan foydalaning.

Beshta standart

StandartHukmHalolHalol emasUlushlar (0–100%)
Akinda fond skriningi (AAOIFI)Halol emas26.97%50.25%
DJIMHalol emas26.97%50.25%
FTSEHalol emas10.22%66.99%
MSCIHalol emas10.22%66.99%
S&PHalol emas33.53%43.68%

Barcha chiziqlar bir xil 0–100% shkalada. Indeks standartlari faqat halol va halol emas ulushini beradi; bo'yalmagan qism shu standart tasniflamaydigan ulush. Qamrov faqat Akinda fond skriningi uchun e'lon qilinadi.

Fond skriningi va to'rtta indeks standarti turli savollarga javob beradi, shuning uchun ular farq qilishi tabiiy. Fond bizning skriningda shubhali, S&P bo'yicha esa halol bo'lishi mumkin; ikkalasi ham to'g'ri.

Fond tarkibi

31 ta aktivdan 1–31, eng kattalari yuqorida · savat sanasi 17 Apr 2023
№AktivUlushAkinda (AAOIFI)DJIMFTSEMSCIS&P
1
TILInstil Bio, Inc.
3.59%Halol emasHalol emasHalol emasHalol emasHalol emas
2
REPLReplimune Group, Inc.
3.54%Halol emasHalol emasHalol emasHalol emasHalol emas
3
IOVAIovance Biotherapeutics, Inc.
3.47%HalolHalolHalolHalolHalol
4
ZYMEZymeworks Inc.
3.45%Halol emasHalol emasHalol emasHalol emasHalol emas
5
ARGXargenx SE
3.42%HalolHalolHalol emasHalol emasHalol
6
GMABGenmab A/S
3.42%HalolHalolHalol emasHalol emasHalol
7
AZNAstraZeneca PLC
3.39%HalolHalolHalolHalolHalol
8
BMYBristol-Myers Squibb Company
3.39%Halol emasHalol emasHalol emasHalol emasHalol emas
9
CRSPCRISPR Therapeutics AG
3.39%Halol emasHalol emasHalol emasHalol emasHalol
10
MRKMerck & Co., Inc.
3.37%HalolHalolHalol emasHalol emasHalol
11
NKTRNektar Therapeutics
3.37%Halol emasHalol emasHalol emasHalol emasHalol emas
12
XNCRXencor, Inc.
3.37%Halol emasHalol emasHalol emasHalol emasHalol emas
13
REGNRegeneron Pharmaceuticals, Inc.
3.36%HalolHalolHalolHalolHalol
14
FATEFate Therapeutics, Inc.
3.33%Halol emasHalol emasHalol emasHalol emasHalol emas
15
GILDGilead Sciences, Inc.
3.33%HalolHalolHalol emasHalol emasHalol
16
RCUSArcus Biosciences, Inc.
3.32%Halol emasHalol emasHalol emasHalol emasHalol emas
17
ATRAAtara Biotherapeutics, Inc.
3.30%Halol emasHalol emasHalol emasHalol emasHalol emas
18
ALLOAllogene Therapeutics, Inc.
3.29%Halol emasHalol emasHalol emasHalol emasHalol emas
19
RUBYRubius Therapeutics, Inc.
3.29%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
20
TRILTrillium Therapeutics Inc.
3.29%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
21
BLUEbluebird bio, Inc.
3.28%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
22
IBRXImmunityBio, Inc.
3.28%Halol emasHalol emasHalol emasHalol emasHalol emas
23
IMABI-Mab
3.25%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
24
IGMSIGM Biosciences, Inc.
3.23%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
25
STTKShattuck Labs, Inc.
3.23%Halol emasHalol emasHalol emasHalol emasHalol emas
26
ALXOALX Oncology Holdings Inc.
3.21%Halol emasHalol emasHalol emasHalol emasHalol emas
27
LEGNLegend Biotech Corporation
3.20%HalolHalolHalol emasHalol emasHalol
28
BGNEBeiGene, Ltd.
3.19%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
29
MGNXMacroGenics, Inc.
3.17%Halol emasHalol emasHalol emasHalol emasHalol
30
YMABY-mAbs Therapeutics, Inc.
3.12%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan
31
Cash&Other—
0.13%BaholanmaganBaholanmaganBaholanmaganBaholanmaganBaholanmagan

"Baholanmagan" — bu kompaniya bo'yicha bizda yaroqli hukm yo'q degani; bunday aktiv hech qachon muvofiq deb hisoblanmaydi.

Akinda fondlar va aksiyalarni qanday tekshiradi